In reply to the Letter to the Editor regarding "Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis" Editor: JP Horcajada

被引:1
|
作者
Gatti, Milo [1 ,2 ,4 ]
Cosentino, Federica [3 ,4 ]
Giannella, Maddalena
Viale, Pierluigi
Pea, Federico [1 ,2 ]
机构
[1] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[2] IRCCS Azienda Ospedaliero Univ Bologna, Clin Pharmacol Unit, Bologna, Italy
[3] Infect Dis Unit, IRCCS Azienda Ospedaliero Univ Bologna, Bologna, Italy
[4] Alma Mater Studiorum Univ Bologna, IRCCS Azienda Ospedaliero Univ Bologna, Dept Med & Surg Sci, Clin Pharmacol Unit, Via Massarenti 9, I-40138 Bologna, Italy
关键词
D O I
10.1016/j.ijantimicag.2024.107168
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis
    Gatti, Milo
    Cosentino, Federica
    Giannella, Maddalena
    Viale, Pierluigi
    Pea, Federico
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
  • [2] Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis
    Gill, Karan
    Takamichi, Baba
    Cooper, Andrew
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (06)
  • [3] Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis
    Zhan, Yangyang
    Mao, Wenchao
    Zhao, Changyun
    Lu, Difan
    Chen, Changqin
    Hu, Weihang
    Yang, Qi
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [4] Carbapenem-resistant Acinetobacter baumannii in patients with burn injury: A systematic review and meta-analysis
    Lima, William Gustavo
    Silva Alves, Geisa Cristina
    Sanches, Cristina
    Antunes Fernandes, Simone Odilia
    de Paiva, Magna Cristina
    BURNS, 2019, 45 (07) : 1495 - 1508
  • [5] SYSTEMATIC REVIEW AND META-ANALYSIS OF MORTALITY PREDICTORS IN PATIENTS WITH CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII
    Du, Xingran
    Yao, Jing
    Deng, Kaili
    Shen, Ziyan
    Feng, Ganzhu
    RESPIROLOGY, 2019, 24 : 24 - 25
  • [6] Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis
    Du, Xingran
    Xu, Xinfeng
    Yao, Jing
    Deng, Kaili
    Chen, Sixia
    Shen, Ziyan
    Yang, Lihua
    Feng, Ganzhu
    AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (09) : 1140 - 1145
  • [7] Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis
    Onorato, Lorenzo
    de Luca, Ilaria
    Monari, Caterina
    Coppola, Nicola
    JOURNAL OF INFECTION, 2024, 88 (03)
  • [8] Clinical impact of active screening cultures for carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis
    Margalit, Ili
    Kunwar, Digbijay
    Gadot, Chen
    Meroi, Marco
    Scardellato, Rebecca
    Zamir, Amber
    Koutsolioutsou, Anastasia
    Goldberg, Elad
    Righi, Elda
    Yahav, Dafna
    AMERICAN JOURNAL OF INFECTION CONTROL, 2024, 52 (12) : 1351 - 1358
  • [9] Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
    Cheng Lyu
    Yuyi Zhang
    Xiaofen Liu
    Jufang Wu
    Jing Zhang
    BMC Infectious Diseases, 20
  • [10] Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
    Lyu, Cheng
    Zhang, Yuyi
    Liu, Xiaofen
    Wu, Jufang
    Zhang, Jing
    BMC INFECTIOUS DISEASES, 2020, 20 (01)